DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation (DMKPQ) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000887247 · DMKPQ · OTC · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000887247 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
DMK Pharmaceuticals Corporation (OTC: DMKPQ) has submitted 1,001+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1995. As a Healthcare sector company with CIK 0000887247, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is DMK Pharmaceuticals Corporation's most comprehensive regulatory disclosure. The most recent DMK Pharmaceuticals Corporation 10-K was filed on 2023-05-01 for fiscal year ending 2023. Historical DMKPQ 10-K annual reports are available from 2004 through 2023.
Investors researching DMK Pharmaceuticals Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
DMKPQ SEC Filings · 8 questionsDMK Pharmaceuticals Corporation (DMKPQ) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,001+ filings and access original documents at no cost. DMK Pharmaceuticals Corporation's CIK is 0000887247.